Pearl Therapeutics (Redwood City, CA), a clinical-stage pharmaceutical company focused on the development of therapeutics for respiratory diseases, closed a $65M Series D financing. Participants include Vatera Healthcare Partners, 5AM Ventures, Clarus Ventures and New Leaf Ventures.
Collective IP | The World’s Largest Technology Transfer Office Marketplace
Providing Unrivaled Comprehensive and Accurate Access to Humankinds Most Valuable and Transformative Assets
Receive Collective IP Account Access HERE